PG Gobbi, ML Ghirardelli, P Avanzini, L Baldini, G Quarta, C Stelitano, C Broglia, C Loni, V Silingardi and E Ascari (2000) “A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin’s lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)”, Haematologica. Pavia, Italy, 85(3), pp. 263-268. doi: 10.3324/%x.